SCRI - Texas Oncology Dallas

Clinical research site in Dallas, Texas

As of July 2026, 1 paid clinical trial is recruiting at SCRI - Texas Oncology Dallas in Dallas, Texas. Active studies at this site cover conditions such as Pancreatic Cancer, Pancreatic Cancer Metastatic and PDAC. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at SCRI - Texas Oncology Dallas (1)

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for Pancreatic Cancer

11 locations incl. Tampa

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07491445·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

More research sites in Dallas

University of Texas Southwestern Medical Center (189 trials)
UT Southwestern Medical Center (168 trials)
UT Southwestern/Simmons Cancer Center-Dallas (73 trials)
University of Texas Southwestern (63 trials)
Baylor University Medical Center (43 trials)
Medical City Dallas Hospital (26 trials)
The University of Texas Southwestern Medical Center (25 trials)
Parkland Memorial Hospital (24 trials)
Mary Crowley Cancer Research (23 trials)
UT Southwestern (23 trials)

Explore more

Paid clinical trials in Dallas, TX · Texas clinical trials